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Abstract.  Two different mRNAs encoding two differ- 
ent nonmuscle myosin heavy chains (MHCs) of ~,,200 
kD have been identified in chicken nonmuscle cells, in 
agreement with the results of Katsuragawa et al. (Katsura- 
gawa,  Y.,  M.  Yanagisawa,  A.  Inoue, and T.  Masaki. 
1989.  Eur. J.  Biochem.  184:611-616).  In this paper, 
we quantitate the content of mRNA encoding the two 
MHCs in a number of different tissues using RNA 
blot analysis with two specific oligonucleotide probes. 
Our results show that the relative content of mRNA 
encoding MHC-A and MHC-B differs in a tissue- 
dependent manner.  Thus the ratio of mRNA encoding 
MHC-A versus MHC-B varies from >9:1  in spleen 
and intestinal epithelial cells, to 6:4 in kidney and 2:8 
in brain.  The effect of serum on MHC mRNA expres- 
sion was studied in serum-starved cultures of chick 
embryo fibroblasts. Serum stimulation results in a 
threefold increase in the mRNA encoding MHC-A and 
a threefold decrease in mRNA encoding MHC-B. 
Using SDS polyacrylamide gels, we have separated 
two nonmuscle MHC isoforms (198 and  196 kD) that 
can be distinguished from each other by two-dimen- 
sional peptide mapping of chymotryptic digests. We 
provide preliminary evidence that the MHC-A mRNA 
encodes the  196-kD polypeptide and that the MHC-B 
mRNA encodes the 198-kD polypeptide. 
M 
vostr~  is a  ubiquitous protein that  demonstrates 
force-generating  ATPase  activity when  it  inter- 
acts with actin.  Myosin is found in all eukaryotic 
ceils and serves as an integral part of the contractile  appara- 
tus in muscle cells. Although best studied in muscle contrac- 
tion, myosin in nonmuscle cells appears to be involved in di- 
verse cellular motile processes (see reference 33 for review), 
including  cytokinesis (7, 22), capping  of surface receptors 
(10,  16,  28) and  chemotaxis (10). In vertebrates, conven- 
tional  myosin  molecules consist of a pair of heavy chains 
(200 kD) and two pairs of light chains (15-28 kD). In addi- 
tion to the 480-kD myosin molecules, Acanthamoeba,  Dic- 
tyostelium  (see references  1,  17 for review)  and  the brush 
border of vertebrate intestinal epithelial cells (6, 12) contain 
a smaller  myosin-like  molecule that preserves many of the 
structural  and functional properties of the globular domain, 
but lacks the rod portion. 
Whereas myosins from vertebrate muscle and nonmuscle 
cells share  common subunit composition and native struc- 
ture, sarcomeric (skeletal and cardiac muscle) and nonsarco- 
meric (smooth muscle and nonmuscle)  myosins from differ- 
ent sources have distinct  features (see references  31, 35 for 
review).  Chemical, immunological,  and molecular genetic 
studies have demonstrated multiple  isoforms of the myosin 
heavy chain  (MHC)  ~ and suggest that sarcomeric and non- 
sarcomeric MHCs constitute a distinct family of isoforms 
1. Abbreviation used in this paper:  MHC, myosin heavy chain. 
(14, 27). Vertebrate sarcomeric MHC isoforms are known to 
be encoded by a highly conserved multigene family (27) and 
expression  of sarcomeric MHC isoforms  is  regulated  de- 
velopmentally, hormonally and in a tissue-specific  and mus- 
cle fiber type-specific manner (13, 18, 23, 36, 37, 39; see ref- 
erence 34 for review). 
On the other hand, the complexity ofMHC isoforms found 
in vertebrate smooth  muscle and nonmuscle  cells and the 
factors regulating the expression of these MHC isoforms are 
less well understood. SDS-PAGE has provided evidence for 
two different MHC isoforms in smooth muscle cells (Mr = 
204 and 200 kD) (4,  8) and isolation of cDNA (26)  and 
genomic clones (2) indicates  that these two MHC isoforms 
are generated by alternative  splicing of mRNA. In addition, 
a developmental  difference  in the expression  of these two 
MHC mRNAs in rabbit aorta has also been reported (19). 
For vertebrate nonmuscle cells, the existence of multiple 
MHC isoforms was first suggested on the basis of chemical 
cleavage experiments  (4).  Recently,  evidence for the pres- 
ence of two vertebrate nonmuscle MHC genes was obtained 
by isolating  two different  eDNA clones (2.8  and 0.9 kb) 
which encode part of the chicken fibroblast MHC (14). Our 
laboratory has isolated eDNA clones encoding  the entire 
amino acid sequence of a chicken  intestinal  epithelial  cell 
MHC (32).  The 0.9-kb clone published by Katsuragawa et 
al.  (14) was included  in this sequence, whereas the 2.8-kb 
eDNA clone showed  differences  throughout the sequence 
with 73% nucleotide identity and 79% amino acid identity. 
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in vertebrate nonmuscle cells, we studied the expression of 
two types of MHCs in a number of avian tissues at different 
stages of development and quantitated the relative content of 
mRNA encoding the MHC isoforms in a number of tissues. 
We also studied the effect of serum in altering the distribu- 
tion of mRNA encoding the two different MHCs in cultured 
fibroblasts.  In addition, we provide preliminary evidence 
that the two genes encoding the two nonmuscle MHC iso- 
forms encode peptides that can be separated by SDS-PAGE. 
Materials and Methods 
DNA Probes 
Two 45-mer single-stranded DNA oligonucleotides, 5'-GGC CTG GAA 
AGT CTC CAT CTC ACT CAG TCT ATT TIC TGC AGC TAG-3' (oligo 
A) and 5'-TTG AT(3 TTT CCT TTC CAT TTC CTC AAG TTC TGC TIC 
CAC TTT TGT-3' (oligo B) were synthesized on a DNA synthesizer (Bio- 
search Model 8700; Millipore Corp., Burlington, MA). Oligo A and B are 
complementary to the mRNA sequence for MHC-A and B, respectively. 
The location of the oligonucleotides in the cDNA clones is shown in Fig. 
I. The oligonucleotides were labeled using T4 polynucleotide kinase (Phar- 
macia  LKB Biotechnology Inc.,  Piscataway,  NJ)  and  [gamma-32P]ATP 
(7,000  Ci/mmol; ICN Biomedicais, Inc., Irvine, CA). 
RNA and DNA Blot Analyses 
Chickens were killed in the laboratory and tissues were used immediately 
for RNA extraction. Intestinal epithelial cells were prepared as described 
previously (3). Total RNA was isolated from tissues or cultured cells by the 
acid guanidinium thioeyanate-phenoi-chioroform extraction method (5). 
The concentration of RNA was determined by reading the A26o for each 
sample before gel electrophoresis. RNA was size-fractionated on a 0.9% 
agarose  gel  containing  formaldehyde by  electrophoresis, and  capillary- 
transferred from the gel to Nytran membranes (Schleicher & Schuell, Inc., 
Keene,  NH)  (24)  and  cross-linked  by  UV  irradiation  using  a  UV 
Stratalinker 2400 (Stratagene Corp., La Jolla, CA). Gels were stained with 
ethidium bromide and photographed before transfer to ascertain that equal 
amounts of intact RNA was loaded. 
To quantitate the amounts of mRNA encoding MHC-A and B, two 45- 
mer DNA oligonucleotides a and b, which are complementary to oligo A 
and B, respectively, were synthesized and used as standards. A  series of 
known amounts of oligo a and b were applied to a Nyti'an membrane using 
a  slot blot apparatus and crosslinked by UV irradiation. To calibrate in- 
dividual autoradiograms of RNA blots probed with the two different oligo- 
nucleotides (oligo A and B), RNA blots and the standard oligonucleotide 
blots (a and b) were processed together. Blots were prehybridized in a 
solution  containing  5×  SSPE  (1×  SSPE  =  0.149  M  NaC1,  0.01 M 
NaH2PO4.H20,  1 mM EDTA, pH 7.4), 5x  Denhardt's solution, 2% SDS, 
I00/~g/ml sonicated and heat-denatured herring sperm DNA for 2 h at 37°C 
and hybridized in the solution containing 40% formamide, 5 × SSPE, 2.5 × 
Denhardt's solution, 0.5% SDS, 10% dextran sulfate, 100 t~g/ml sonicated 
and heat-denatured herring sperm DNA and [32P]5'-end labeled oligonu- 
cteotides (5-10  ×  l0  s epm/#g, 2-4  x  107 cpm/ml) at 37"C.  The final 
wash contained 0.3×  SSC (Ix  SSC  =  0.15 M NaCI, 0.015 M sodium ci- 
trate, pH 7.0) plus 0.5% SDS at 57°C. The blots were exposed to Kodak 
XAR x-ray film for a period of 4-24 h at -70"C using intensifying screens 
and developed with an automatic processor (Kodak X-Groat M20 Proces- 
sor,  Eastman  Kodak  Company,  Rochester,  NY).  Autoradiograms  were 
scanned using a laser densitometer (LKB Utroscan XL) to quantitate the 
relative amounts of radioactivity. Only those bands that were in the linear 
response range of the film were used in quantitation. 
Chicken genomic DNA was obtained from Clontech Lab., Inc.  (Palo 
Alto, CA). 30/zg of genomic DNA was digested using the indicated restric- 
tion enzymes and the digests were size-fractionated by field inversion gel 
electrophoresis in a 0.7%  agarose gel. DNA was transferred to a Nytran 
membrane (24) and probed as described above. 
Cell Culture 
Chicken embryonic fibroblasts were obtained from American Type Culture 
Collection (Rockville, MD) and maintained in Eagle's minimum essential 
medium with Earle's balanced salt solution and nonessential amino acids 
supplemented with 5 % tryptose phosphate broth (basal medium) and 5 % 
FBS (GIBCO BRL Life Technologies, Inc., Gaithersburg, MD). The cells 
were grown in 75-cm  2 flasks to  confluence in the above medium.  The 
medium was switched to the basal medium plus0.5 % FBS for 24 h and then 
the basal medium plus 1 mg/ml bovine albumin (Pentex-fatty acid-frea frac- 
tion V; Miles Laboratories Inc., Naperville, IL) for another 24 h. The cells 
were then stimulated with 10%  FBS. For RNA extraction, the cells were 
washed in PBS and a solution containing guanidinium thiocyanate (5) was 
added directly to the monolayer culture. Various inhibitors, such as cyclo- 
heximide (30 t~g/ml),  actinomycin D  (3 ttg/rul),  and mitomycin C  (0.2 
/zg/ml)  were added to the medium 15 min before serum stimulation. 
For [3H]thymidina  incorporation, cells were plated on 24-well plates 
and the medium changed as for RNA extraction. The cells were pulse- 
labeled for the last  1 h of the incubation period with [3H]thymidine (0.4 
/~Ci/ml, 6.7 Ci/mmol; New England Nuclear, Boston, MA). The cells were 
then washed with ice-cold PBS and [3H]thymidine that was incorporated 
into DNA was precipitated by addition of 10% TCA and assayed for radio- 
activity using an aqueous counting scintillant in a scintillation counter. 
Preparation of 1issue Extracts (Crude Actomyosin) 
Tissue or isolated intestinal epithelial cells were homogenized in a buffer 
containing 40 raM MOPS-NaON (pH 7.6),  0.6 M  NaCI,  5 mM EDTA, 
5 mM EGTA, 1 mM DTT,  and 0.1 mM PMSF and centrifuged at 7,000 g 
for 10 rnin. ATP was added to the supernatant to a final concentration of 
10 mM and centrifuged at 3,000 g for 20 min. The resulting supematant 
(high salt-ATP extract) was fractionated by ammonium sulfate (30-60% 
saturation) in the presence of 10 mM MgSO4 and 5 mM ATP and dialyzed 
against a buffer containing 40 mM MOPS-NaOH (pH 7.6),  0.6 M NaC1, 
1 mM EDTA,  1 mM EGTA, 1 mM DTT, and 0.1 mM PMSF. The high salt- 
ATP extracts or the 30-60%  ammonium sulfate fraction were used for 
SDS-PAGE. 
SDS-PAGE 
Gel electrophoresis  was performed in a 5 % acrylamide gel with 0.065 % bis- 
acrylamide, using the buffer system of Laemmli (20). To resolve the non- 
muscle MHCs, electrophoresis  was carried out until bromophenol blue dye, 
loaded with the samples, reached the bottom of  the gel. At this time another 
aliquot of dye was applied into the wells and electrophoresis was continued 
until the second dye front reached the bottom of the gel. Under these condi- 
tions, MHCs are resolved approximately one-third to one-fourth of the way 
from the bottom of the gel. 
Two-dimensional  Peptide Mapping of 
Radioiodinated Proteins 
Radioiodination and the mapping of chymotryptic peptides of proteins re- 
covered from polyacrylamide gels were carried out as described previously 
(15),  except chymotrypsin (final  concentration  100  t~g/ml;  Worthington 
Biochemical Corp., Freehold, NJ) was used in this study instead of  trypsin. 
Results 
Specificity of the Probes 
To study the expression of mRNA encoding MHC-A and 
MHC-B  we  synthesized  two  oligonucleotides  (45  mers), 
oligo A  and oligo B, which are complementary to the two 
different mRNAs in an area of relative sequence dissimilar- 
ity. Fig. 1 shows the location of the two probes with respect 
to the MHC. In the area selected, only 40% of the nucleotide 
sequence is identical as compared with 73 % nucleotide iden- 
tity when the published nucleotide sequence for MHC-B (14) 
is compared with MHC-A (32).  The specificity of these oli- 
gonucleotides was tested using chicken genomic Southern 
blot analysis. As shown in Fig.  1 (left), oligo A hybridized 
to a  single DNA fragment using three different restriction 
digests of genomic DNA. When the same blot was stripped 
and reprobed with oligo B, it also hybridized to a single, but 
different DNA fragment in each of the three lanes (Fig.  1, 
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Figure 1. Southern blot analysis of chicken 
genomic DNA. Chicken genomic DNA (30 
#g) was digested with Xba I (lanes 1 ), Eco 
RI (lanes 2) or Hind III (lanes 3), electro- 
phoresed in a 0.7 % agarose gel and trans- 
ferred to a nylon membrane. The same blot 
was hybridized in all three panels with oligo 
A  (left), oligo B (middle),  or both oligo A 
and B (right).  The diagram below the au- 
toradiograms depicts two different cDNAs 
for chicken nonmuscle MHCs and the loca- 
tion  of  the  two  oligonucleotide probes. 
MHC-A: cDNA isolated from intestinal ep- 
ithelium library (32).  Solid box indicates 
the coding region (5,877  nucleotides) and 
wavy line the untranslated regions. An ar- 
row indicates the codon for the proline resi- 
due just before the helical rod region. Oligo 
A (45 mer) is complementary to the mRNA 
sequence  from  nucleotide 2,584  to 2,628 
(where nucleotide  1 is A  of the initiating 
methionine codon for MHC-A).  MHC-B: 
cDNA isolated from a cultured fibroblast li- 
brary (14).  This clone corresponds to the 
sequence from nucleotide 1,384 to 4,156 of 
the MHC-A coding region. An arrow indi- 
cates the codon for the proline residue, as 
described above. Oligo B (45 mer) comple- 
ments the mRNA encoding the same por- 
tion of the MHC-B molecule that Oligo A 
encodes in MHC-A. 
middle).  Fig.  1 (right) shows the same blot hybridized with 
both oligo A  and oligo B to confirm that the two probes hy- 
bridize to distinct DNA fragments. These results show that 
oligo A and oligo B can be used to distinguish the two differ- 
ent genes and also confirm that the two MHCs are encoded 
by different loci in the chicken genome (14). 
Cell 7)2pe- and Tissue-dependent Expression 
of Two MHC mRNAs 
Expression of the  two  MHC  mRNAs  in  cultured chicken 
fibroblasts and  isolated intestinal epithelial cells was ana- 
lyzed by Northern blots. Oligo A hybridized to a 7.3-kb mes- 
Kawamoto and Adelstein  Nonmuscle Myosin Heavy Chain Isoforms  917 Figure 2. Differential expression of two nonmuscle MHC mRNAs. 
Each lane contains 30 #g of total RNA. The same blot was hybrid- 
ized in both panels with oligo A (left) and oligo B (right). The blot 
hybridized  with  oligo B was exposed to x-ray film for approxi- 
mately twice as long as that hybridized with oligo A. (Int. Epith.) 
Intestinal epithelial cells. 
sage in both fibroblasts and epithelial cells (Fig. 2). In con- 
trast, oligo B hybridized to mRNA isolated from fibroblasts, 
but not from epithelial cells (Fig. 2). The size of the message 
encoding MHC-B is also 7.3 kb. Thus, the mRNAs encoding 
MHC-A and MHC-B are the same size, but the expression 
of the two MHC mRNAs differs, depending on cell type. 
Fig. 3 shows the expression of nonmuscle MHC mRNAs 
in  a  variety of chicken  tissues  and  developmental  stages 
(adult, newborn and 15 d-old embryo). The MHC-A mRNA 
is detected in all tissues examined, including muscle tissues. 
Fibroblasts,  spleen  and  intestinal  epithelium  (lanes  5,  8, 
and 10) contained relatively more of the mRNA encoding 
MHC-A. On the other hand, relatively more mRNA was de- 
tected with oligo B in aorta and brain (lanes 4 and 6). The 
bands detected by the two oligos in muscle tissues are not due 
to  cross-hybridization  with  skeletal,  cardiac,  or  smooth 
muscle MHC mRNA since cDNA probes for the respective 
muscle MHCs hybridize to distinct bands of the expected 
smaller size (23, 38) on the same blots (data not shown). The 
relative distribution of  mRNA encoding MHC-A and MHC-B 
in different nonmuscle tissues is similar throughout the de- 
velopmental stages we analyzed, although more mRNA en- 
coding MHC-B is detected in embryonic skeletal and gizzard 
smooth muscle compared to adult chicken muscle. Because 
of the relatively small amounts of mRNA encoding nonmus- 
cle MHCs in skeletal and gizzard cells, and the possible con- 
tamination of these cells with nonmuscle cells, these experi- 
ments must be interpreted with caution. 
Differential Effects of Serum on Expression 
of Two MHC mRNAs 
The above data show that both MHC-A and B mRNAs are 
present in most tissues, including cultured fibroblasts. Next 
we studied whether the level of the two MHC mRNAs can 
be altered  in  cultured  fibroblasts by extracellular  signals. 
Chicken embryo fibrobl~ists  were grown to confluence and 
starved in a  serum-free medium. The quiescent cells were 
then stimulated with  10%  FBS and RNA was extracted at 
various times for RNA blot analysis. The same blots or blots 
treated in an identical manner using the same preparation of 
mRNA were hybridized with oligo A and oligo B. Represen- 
tative data are shown in Fig. 4 A and data from a number 
of sets of experiments are summarized as a graph in Fig. 4 
B (top two panels). The expression of MHC-A mRNA began 
to  increase  one  hour  following  serum  stimulation  and 
reached a peak at 6 h. Thereafter, the level declined, and by 
26 h, it returned to the control value. In contrast, the level 
of MHC-B mRNA decreased 6-10 h after serum stimulation 
and, thereafter, returned to the control level. The MHC-A 
mRNA level was increased approximately threefold in stimu- 
lated cells as compared with resting cells, and the MHC-B 
mRNA was decreased by about one-third at 6  h.  Chicken 
embryo  fibroblasts  enter  the  Go/Gt phase  when  they  are 
deprived of serum. Addition of serum to such quiescent cells 
triggers an increase in the rate of initiation of DNA synthesis 
Figure 3.  Tissue-dependent expression of two nonmuscle MHC mRNAs.  Each lane contains  30 #g of total RNA from skeletal muscle 
(lanes 1), cardiac ventricle (lanes 2), gizzard smooth muscle (lanes 3), aorta (lanes 4), brain (lanes 6), liver (lanes  7),  spleen (lanes 
8), kidney (lanes 9), and intestinal epithelial cells (lanes 10) from adult (left), 6-d-old newborn (middle), and 15-d-old embryo chickens 
(lane 10 is absent in the embryo panel). Lanes 5 of all three panels contains 30 #g of the same preparation of RNA from cultured embryo 
fibroblasts as a standard in order to allow a comparison of the three panels. The same RNA blots were probed with oligo A (top) or oligo 
B (bottom). Exposure time to x-ray film was about the same for all blots. 
The Journal of Cell Biology. Volume 112, 1991  918 Figure 4. Effect of serum on nonmuscle MHC mRNA expression.  (A) Chicken embryo fibroblasts were grown to confluence and starved 
in serum-free medium as described in Materials and Methods. The quiescent cells were then stimulated  with 10% FBS (serum +) or not 
stimulated  (serum -). RNA was extracted  at each of the indicated  time points.  Each lane contains 30 ttg of total RNA. The RNA blots 
were probed with oligo A (top) or oligo B (bottom). To obtain a signal  for quantitative  analysis by densitometry,  the blots probed with 
oligo B were exposed for a longer time.  (B) Expression of MHC-A mRNA (top) and MHC-B mRNA (middle). The autoradiograms of 
the RNA blots were analyzed densitometrically and the results are expressed as percent of the signal intensity measured in parallel  cultures 
not stimulated  with serum. The data shown are the mean +  SD, n  =  3 except for the 6-h time point (n =  6). Incorporation of [3H]thymi- 
dine (bottom). The ceils were pulse-labeled  for the last  1 h at each of the indicated  time points.  Results are expressed  as percent of the 
maximum [3H]thymidine incorporation obtained at the 15-16-h time period. The radioactivity detected in parallel  cultures  not stimulated 
with serum were subtracted  from those in serum-stimulated  cultures.  The data shown are the mean  +  SD, n  =  3. 
after a  lag phase.  As shown in Fig. 4 B  (bottom),  [3H]thy- 
midine  incorporation  starts  after  a  10-h  lag  period  (this 
period represents the GI phase of the cell cycle) and reaches 
a maximum at 15 h after serum stimulation, under the given 
conditions.  Thus,  the  maximum  changes in both  MHC-A 
and B  mRNA expression occur during the GI phase. 
Changes in mRNA expression can be affected by increased 
or  decreased  transcription  or  posttranscriptional  changes 
affecting mRNA stability. Inhibitors of mRNA transcription 
or translation were used to determine the level of  control. All 
inhibitors were added to the quiescent cultures 15 rain before 
serum  stimulation.  The cultures  were harvested  6  h  later, 
and the purified RNA was analyzed by Northern blots. The 
serum-induced changes in the MHC-A and B mRNA levels 
were still seen in the presence of cycloheximide, an inhibitor 
of protein synthesis (Fig. 5). In contrast, actinomycin D, an 
inhibitor  of  transcription,  abolished  the  serum-induced 
changes  in  both  MHC-A  and  B  mRNAs  (Fig.  5).  These 
results suggest that the changes in nonmuscle MHC mRNAs 
seen after serum stimulation is regulated,  at least to some 
extent,  at the transcriptional  level.  Additionally,  we tested 
the  effect of an  inhibitor  of DNA synthesis,  mitomycin C 
(Fig. 5). Expression of neither gene was affected by mitomy- 
cin C, a finding consistent with the notion that changes in the 
expression  of both  genes is  a  prereplicative  rather  than  a 
postreplicative  event. 
Quantitation of MHC mRNAs in Four Tissues 
To quantitate the relative amounts of MHC-A and B mRNAs 
in four different tissues,  we used oligonucleotides which are 
complementary to oligo A  and B  (i.e.,  the same strand as 
mRNA), as standards  for MHC-A and B mRNAs (see Fig. 
6 A). Known amounts of oligonucleotides were applied to a 
Nytran membrane  using  a  slot blot apparatus,  UV cross- 
linked  and  hybridized  in  the  same  hybridization  solution 
used for RNA blots. Oligo A and B were labeled at the 5' end 
phosphate using  [gamma-32p]ATP, so that both probes had 
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MHC  mRNA  expression.  The  quiescent 
chicken embryo fibroblasts were stimulated 
with 10% FBS (serum 4-) or unstimulated 
(serum -) in the presence of cycloheximide 
(30 #g/ml, Cyc.), actinomycin D (3/zg/ml, 
Act. D), mitomycin C (0.2/~g/ml, Mit. C) 
or  no  inhibitors  (Cont.). RNA  was  ex- 
tracted 6 h after serum stimulation.  Each 
lane contains 20 #g of total RNA for prob- 
ing with oligo A (top), and 40/~g (the same 
RNA preparation used for oligo A) for oligo 
B.  The blot probed with oligo B was  ex- 
posed for a longer time to obtain a signal of 
comparable intensity. 
the same specific activity and RNA blot~ were then exposed 
along with the standard oligonucleotide blots, and individual 
autoradiograms were scanned.  The intensity of the signals 
were calibrated,  based on that of the standard blots (Fig. 6 
A).  Fig.  6  B  shows  the  distribution  of mRNA  encoding 
MHC-A and B for four different tissues. The relative amounts 
of MHC-A and B mRNA are quite different,  depending on 
the tissue.  In intestinal epithelial cells and spleen,  >95 % of 
the mRNA is the A-form, whereas in brain >80%  is the B 
form.  Kidney contains roughly equal amounts of A  and B 
mRNA.  Fig.  6  B  also  indicates  that  the  content  of both 
MHC-A and B mRNAs is similar comparing intestinal epi- 
thelium, spleen and kidney, but the MHC mRNA content in 
brain is approximately one-third of the above tissues. 
Separation of Two MHCs by SDS-PAGE in 
Four 7Issues 
In an attempt to distinguish  the two nonmuscle MHC iso- 
Total Content 
B  0  50  100%  (MHC-A + MHC-B) 
S ,ean  1 
Kidney  ~.~  0.8 "~, 0.9 
Brain  FJ,~  '  0.3 ,'~, 0.4 
100  50  0% 
[]  : MHC-A,  []  : MHC-B 
Figure 6. Quantitation  of mRNA encoding MHC A and B. (.4) 4, 
10, and 25/~g (from left to right) of total RNA extracted  from the 
tissues  indicated  was electrophoresed  and transferred  to Nytran. 
The indicated amounts of  oligonucleotides  a and b (complementary 
to oligo A and B, respectively)  were applied  to the membrane and 
crosslinked.  The RNA blots  (top) and oligonucleotide  blots (bot- 
tom) were hybridized with  oligo A  (left) or oligo B  (right)  and 
processed together through autoradiography,  at all steps. The blots 
shown in left and right panels  contain the same samples  loaded 
identically. (Int. Epith.)Intestinal epithelial  cells. (B) Distribution 
of mRNAs encoding MHC-A and B. Three independent  sets of au- 
toradiograms of  RNA blots and standard oligonucleotide blots were 
analyzed densitometrically.  Bars show mean +  SD. The total con- 
tent of mRNA encoding MHC-A and B in intestinal epithelial cells 
was taken as  1. 
The Journal of Cell Biology, Volume 112, 1991  920 Figure 7. Separation of two nonmuscle MHCs by SDS-PAGE. (A) 
MHCs in tissue extracts from intestinal epithelial cells (IE, lane 1 ), 
brain (Br, lane 3) and gizzard smooth muscle (Gz, lane 6) were 
separated  by  SDS-PAGE and  the  proteins  were  stained  with 
Coomassie blue. Lane 2 contains a mixture of the extracts from in- 
testinal epithelial cells and brain; lane 4, brain and gizzard and lane 
5, intestinal epithelial cells and gizzard. Only the part of  the gel that 
includes MHCs is shown. NMHCjg~:  196-kD nonmuscle MHC; 
NMHCt98.  198-kD nonmuscle MHC;  SMHC2oo: 200-kD  smooth 
muscle MHC; SMHC2o4: 204-kD smooth muscle MHC. The bro- 
ken line indicates that the MHC is absent from the panel to the fight 
of the line. (B) MHCs in tissue extracts from intestinal epithelial 
cells (IF.), kidney (Ki), brain (Br), and spleen (Sp) were separated 
by SDS-PAGE. The band labeled with an asterisk in the spleen lane 
is the 204-kD smooth muscle MHC. 
forms at the protein level, we made use of  low concentrations 
of acrylamide and bisacrylamide in  SDS-PAGE.  This gel 
system was originally used to separate the two smooth mus- 
cle MHC  (204 and  200  kD)  isoforms from a  nonmuscle 
MHC isoform (196 kD) (15, 29), but we modified the run- 
ning condition as described in Materials and Methods.  In 
this  system,  the MHC  extracted from intestinal epithelial 
cells migrates as a single band, as seen in Fig. 7 A, lane 1. 
The MHC from chicken brain also migrates predominantly 
as a single band as detected by Coomassie blue, but slightly 
slower than the intestinal epithelial MHC (Fig. 7 A, lane 3). 
The different migration of  the epithelial cell and brain MHCs 
is confirmed by running them together (Fig. 7 A, lane 2). We 
estimated the relative molecular mass of the intestinal epi- 
thelium and brain MHCs as  196 and  198 kD, respectively. 
Using the same gel system, the two MHCs of gizzard smooth 
muscle myosin also can be separated (Mr 204 and 200 kD) 
and both smooth muscle MHCs are seen to migrate slower 
than the two nonmuscle MHCs (Fig. 7 A, lane 6). Coelec- 
trophoresis  of brain  MHC  or intestinal  epithelium MHC 
with smooth muscle MHCs shows that brain and intestinal 
epithelium MHCs migrate faster than the two smooth muscle 
MHCs and clearly indicates that the distance between the in- 
testinal  epithelium MHC  and the 200-kD  smooth muscle 
MHC is greater than that between brain MHC and the 200- 
kD smooth muscle MHC  (Fig.  7 A,  lanes 4 and 5). 
Since intestinal epithelial cells contain mRNA  encoding 
essentially only MHC-A and >80% of the brain mRNA en- 
codes MHC-B, it is possible that the two polypeptides (196 
and 198 kD) represent products of the two different mRNAs. 
Fig.  6  shows that kidney contains  ~60%  MHC-A mRNA 
and spleen contains >95 % MHC-A mRNA.  Therefore, we 
also analyzed the MHC peptides extracted from these tissues 
using  the  porous  polyacrylamide  gel.  As  expected,  the 
MHCs from kidney resolved as a doublet which comigrates 
with both intestinal epithelium and brain MHCs,  whereas 
the MHC from the spleen migrates with the same relative 
molecular mass as intestinal epithelium MHC (Fig.  7 B). 
The asterisk in the spleen lane indicates a band that comi- 
grates with the 204-kD smooth muscle MHC. We confirmed 
the identity of this polypeptide by immunoblots, using an an- 
tibody that is specific for smooth muscle MHCs (15).  Our 
results above suggest that MHC-A mRNA encodes the 196- 
kD  polypeptide and that MHC-B mRNA  encodes for the 
198-kD polypeptide. 
In the course of examining the migration of the MHCs 
from a number of different tissues and cell lines (including 
human cell lines), we were able to confirm that those cells 
and tissues expressing predominantly MHC-A mRNA  en- 
coded a polypeptide chain of 196 kD. We did, however, find 
one  exception.  Chicken  embryonic  fibroblasts  expressed 
predominantly MHC-A mRNA (see Fig. 3), yet it encoded 
a polypeptide migrating more slowly than chicken intestinal 
epithelial cells (data not shown). We were able to confirm 
that the polypeptide chain was, in fact, MHC-A by using two- 
dimensional peptide mapping of iodinated MHCs which, as 
demonstrated  below,  can  be used  to  distinguish  between 
MHC-A and MHC-B. 
To examine the differences in protein structure between 
the MHCs obtained from intestinal epithelial cells and brain, 
we prepared chymotryptic peptide maps of iodinated MHCs 
following separation of MHCs by SDS-PAGE. The peptide 
maps  prepared  from the  196-  (intestinal  epithelium)  and 
198-kD (brain) MHCs show a large number of radioactive 
spots in common, but they also demonstrate that there is a 
well-defined and reproducible difference as noted by the ar- 
rows (Fig.  8, A and B).  Fig.  8 C shows a map of an equal 
mixture of intestinal epithelium and brain chymotryptic pep- 
tides, and confirms the differences indicated in Fig. 8, A and 
B. Fig. 8 D is a map of the chymotryptic peptides obtained 
from the digestion of the kidney MHCs.  As shown in Fig. 
7 B, kidney contains approximately equal amounts of both 
the 198- and 196-kD MHC. As expected, the map of  the iodi- 
nated kidney MHC peptides resembles the map obtained by 
mixing equal amounts of the intestinal epithelium and brain 
peptides (compare Fig. 8, C and D). These results show that 
the two nonmuscle MHCs are similar, but not identical, and 
support the idea that intestinal epithelium and brain MHCs, 
which can be separated by SDS-PAGE, differ in their pri- 
mary structure. 
Discussion 
In  this  study,  we  demonstrate  the  tissue-  and  cell  type- 
specific expression of two  nonmuscle MHC  mRNAs  and 
the effect of serum stimulation on the expression of the two 
MHC  mRNAs  in  cultured  fibroblasts.  Although  some of 
our results agree with those of Katsuragawa et al. (14), there 
are important differences between the two studies.  First of 
all, to quantitate the distribution of mRNA encoding the two 
MHC isoforms, we used oligonucleotide probes that were la- 
beled to the same specific activities.  Each oligonucleotide 
probe was shown to be specific for a particular MHC since 
it hybridized to a  single band in a  genomic Southern blot 
Kawamoto and Ad¢lstein Nonmuscle Myosin Heavy Chain lsoforms  921 Figure 8.  Comparison of two-dimensional chymotryptic peptide maps of iodinated MHCs. (A)  196-kD nonmuscle MHC obtained from 
intestinal epithelial cells.  (B)  198-kD nonmuscle MHC obtained from brain.  (C) A mixture of equal amounts (based on measurement 
of t25I radioactivity) of intestinal epithelial cell and brain nonmuscle MHCs.  (D) Kidney MHCs which contain both  196- and  198-kD 
MHCs (see Fig. 7 B). The appropriate MHC(s) was cut from an SDS-5% PAGE, labeled with t25I, and digested with chymotrypsin. Sam- 
pies were applied to silica gel plates and subjected to electrophoresis (E) and ascending chromatography (C) and autoradiography as previ- 
ously described (15).  Single head arrows point to peptides unique to intestinal  epithelial cell MHCs.  Double headed arrow points to a 
peptide unique to the brain MHC.  (Int.  Epith.) Intestinal epithelial. 
(Fig.  1) and also hybridized to its complement of nucleotides 
by a  factor of >1@ than it did to a complement of the other 
oligonucleotide  probe (Fig.  6  A).  In contrast,  Katsuragawa 
et al.  employed cDNA probes from the coding  region that 
were  labeled  by  random  priming.  Quantitative  analysis  of 
our Northern blots showed that spleen and intestinal epithe- 
lial  cells  are  particularly  enriched  for  mRNA  encoding 
MHC-A  whereas  brain  is  enriched  in  mRNA  encoding 
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equal amounts of both mRNAs (Fig. 6). 
Our results extend those reported by Katsuragawa et al. 
(14) by including newborn (6 d) as well as adult and embryo 
tissues. In addition, we included a number of different non- 
muscle tissues in our analysis of embryonic tissues, whereas 
they only analyzed muscle and brain. They found that em- 
bryonic tissue contains significantly more mRNA encoding 
MHC-B than adult, whereas our studies show that, with the 
exception of skeletal and gizzard smooth muscle cells, for 
any given tissue there is no major change in this distribution 
comparing embryonic, newborn and adult. Rather, the ex- 
pression of the two nonmuscle MHC mRNAs is dependent 
on the tissue or cell type. Thus, although the sarcomeric 
forms of the contractile proteins are expressed in a develop- 
mental and tissue-specific manner (18, 23, 34, 36, 37),  we 
find that the two nonmuscle MHC genes are expressed at 
similar levels throughout different developmental stages. 
The presence of two different MHC isoforms in vertebrate 
nonmuscle cells raises questions about whether these myo- 
sins serve specific functions. Although we cannot answer this 
question directly, the ability of serum to alter MHC mRNA 
expression is of note (Fig. 4).  Previous work has demon- 
strated that serum contains a number of factors capable of 
altering the expression  of mRNA  encoding a  number of 
cytoskeletal proteins (9, 11, 25). In this paper, we show that 
stimulation of quiescent fibroblasts with serum results in an 
increase  in  mRNA  encoding  MHC-A  and a  decrease  in 
mRNA encoding MHC-B. It is well established that the acti- 
vation of certain genes is required for quiescent cells to re- 
spond to mitogens and proliferate. These genes include the 
proto-oncogene c-fos and c-myc (11, 21), and genes encoding 
cytoskeletal proteins such as nonmuscle actins (11, 25) and 
vimentin (9) and others, as yet unidentified (21). The rapid 
accumulation of MHC-A mRNA after serum stimulation, 
and the fact that this effect does not require de novo protein 
synthesis (Fig. 5), suggests that the increased expression of 
MHC-A mRNA and the concomitant decreased expressed of 
MHC-B mRNA is due to growth factor(s) present in the 
serum. 
Our working hypothesis is that this alteration in MHC 
mRNA expression might also be necessary for cell prolifera- 
tion. In addition to the experiments cited above (see Fig. 4), 
we have also observed a similar phenomenon with smooth 
muscle cells that are placed in culture. Previous experiments 
by us (15),  as well as others (29),  demonstrated that when 
smooth muscle cells are placed into primary culture, the 
smooth  muscle  MHC  isoforms  (204  and  200  kD)  are 
replaced by nonmuscle isoforms,  particularly during log- 
phase  growth.  Experiments  similar  to  those  shown here 
for chicken embryonic fibroblasts  show that proliferating 
smooth muscle cells contain a high proportion of the mRNA 
encoding  MHC-A  (Kawamoto,  S.,  unpublished  observa- 
tion). This is in contrast to the mRNA content of intact vas- 
cular tissue that is enriched for mRNA encoding MHC-B 
(see Fig. 3). Although it is tempting to postulate, on the basis 
of these experiments, a specific function for MHC-A in cel- 
lular proliferation, for example, a role in cytokinesis (7, 22), 
it must be pointed out that the serum-induced changes in 
MHC mRNA described here appear to be transient and oc- 
cur before DNA replication. Thus, the exact function of the 
myosin isoforms remains to be determined. 
The presence of two different mRNAs encoding nonmus- 
cle MHCs suggests the existence of two different protein iso- 
forms.  Using SDS-PAGE,  we were  able to  separate two 
MHC species with different Mrs  (196  and  198  kD).  Our 
data suggest that MHC-B mRNA encodes the 198-kD MHC 
and MHC-A mRNA encodes the 196-kD MHC, but we have 
not yet demonstrated this directly. Moreover, we cannot rule 
out the presence of additional MHC isoforms, although we 
have failed to detect their presence to date screening multiple 
libraries and probing genomic Southern blots at low strin- 
gency.  The  existence of additional,  smaller forms of the 
MHC  (e.g.,  110  kD)  similar to those found in  intestinal 
brush border cells (6,  12),  is also not precluded by these 
studies. 
Two-dimensional chymotryptic peptide  maps  prepared 
from 196 kD and 198 kD MHCs show a number of distinct 
radioactive peptides with many common peptides (Fig. 8). 
In the procedure used for this study, mostly tyrosine residues 
are iodinated, and other amino acid residues, such as histi- 
dine, cysteine, tryptophan, and methionine are labeled to a 
lesser extent (39). Although cDNA cloning allows for direct 
comparison of the amino acid sequence between the chicken 
smooth muscle (38) and nonmuscle MHC-A (32), only part 
of the MHC-B sequence (14) has been published to date. 
Both the chicken intestinal epithelial cell MHC (32) and the 
human macrophage MHC cDNA-derived sequences (30) are 
for  MHC-A.  The  amino acid  sequence  identity between 
chicken MHC-A and the chicken 204-kD  smooth muscle 
MHC is 84% in the head region and 69% in the rod region 
with 80-85 % of the tyrosine residues located in the head re- 
gion. Similar values are found in comparing MHC-A and B 
(unpublished observation, this laboratory). Nevertheless, at 
least three of the chymotryptic peptides generated from the 
196-kD  intestinal epithelium MHC and the  198-kD  brain 
MHC migrate to unique positions using peptide mapping, 
confirming that the two MHCs are related, but distinct pro- 
teins. 
Burridge and Bray have demonstrated that platelet and 
brain myosins are distinct by analysis of fragments of myosin 
produced by chemical cleavage at cysteine residues (4), al- 
though they were not able to separate the MHCs in their 
SDS-PAGE system. It is of note that they found that kidney 
and fibroblast myosin generated a  pattern consistent with 
their being a simple mixture of brain and platelet myosins. 
This  agrees  with  our  observation  that  kidney  contains 
roughly equal amounts of both the 196- and 198-kD MHCs. 
Together,  the results presented in this paper suggest that at 
least two types of nonmuscle MHC exist both at the peptide 
and mRNA levels. These results should help in defining the 
functional differences between the two MHC isoforms. 
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